Literature DB >> 35331986

Covid-19: What do we know about the delta omicron recombinant variant?

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2022        PMID： 35331986     DOI： 10.1136/bmj.o792

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Recombinant SARS-CoV-2 variants XD, XE, and XF: The emergence of recombinant variants requires an urgent call for research - Correspondence.

Authors:  Chiranjib Chakraborty; Manojit Bhattacharya; Ashish Ranjan Sharma; Kuldeep Dhama
Journal:  Int J Surg       Date:  2022-05-13       Impact factor: 13.400

2.  Do the Successive Waves of SARS-CoV-2, Vaccination Status and Place of Infection Influence the Clinical Picture and COVID-19 Severity among Patients with Persistent Clinical Symptoms? The Retrospective Study of Patients from the STOP-COVID Registry of the PoLoCOV-Study.

Authors:  Michał Chudzik; Mateusz Babicki; Joanna Kapusta; Damian Kołat; Żaneta Kałuzińska; Agnieszka Mastalerz-Migas; Piotr Jankowski
Journal:  J Pers Med       Date:  2022-04-28

3.  The recombinant variants of SARS-CoV-2: Concerns continues amid COVID-19 pandemic.

Authors:  Ranjan K Mohapatra; Venkataramana Kandi; Hardeep S Tuli; Chiranjib Chakraborty; Kuldeep Dhama
Journal:  J Med Virol       Date:  2022-04-27       Impact factor: 20.693

4.  Emerging SARS-CoV-2 Mutational Variants of Concern Should Not Vary in Susceptibility to Microbicidal Actives.

Authors:  M Khalid Ijaz; Raymond W Nims; Julie McKinney
Journal:  Life (Basel)       Date:  2022-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.